The cardiovascular landscape is fast changing. The ongoing medical technology modernization, driven by the integration of AI and wearables, is encouraging medical device companies to develop smarter, connected devices capable of detecting cardiovascular issues with greater accuracy. According to a report published by Growth Plus, the cardiovascular devices market is expected to reach $97.48 billion by 2030 at a CAGR of 6.5 percent, owing to increased cardiovascular disease prevalence and the adoption of technologically advanced products.
From the monitoring standpoint, portable and compact electrocardiograms (ECGs) are playing a catalytic role in accurately visualizing the cardiovascular issues faster, and on the go. On the diagnostic front, 3D depictions of a patient’s heart are helping physicians better understand the nature of the heart disease and facilitate more precise treatment.
To put the spotlight on such key developments in the industry, MedTech Outlook illustrates how the medical technology space is making it imperative that health solutions keep up with the newest technology trends. This edition also features thought leadership articles from subject matter experts. Some of the exclusive insights are authored by Michael Dale, Senior Vice President at Abbott [NYSE:ABT], Thomas Draper, Vice President, Wellstar Center for Cardiovascular Care, and Jennifer Ledbetter, RN, MSN, Vice President of Operations at Medical City Heart Hospital and Medical City Spine Hospital HCA Healthcare. They shed light on critical unmet needs of people with complex heart issues, the ability to measure vital data with wearables, and the use of venoarterial extra-corporeal membrane oxygenation for mechanical circulatory support of heart patients.
In this edition of MedTech Outlook, we also bring to you the story of the top cardiovascular devices’ solution providers leveraging technology to redefine heart monitoring. In the list, Coala Life stands out for its patch-free remote monitoring system with diagnostic quality ECG and integrated stethoscope. We also bring to you the story of Corsano Health, whose wearables can provide true continuous data at high resolution and in raw format.
Through the following pages, we aim to shine a light on the innovative trends and latest developments in the cardiovascular devices segment. We would like to know your thoughts.








![Abbott Laboratories [NYSE:ABT] - Top Cardiovascular Devices Companies Abbott Laboratories [NYSE:ABT]](https://www.medicaltechoutlookapac.com/company_logos/eops3Untitled-4.jpg)






